Business Segments · Research expenses
Pharmaceuticals — Research expenses
Vertex Pharmaceuticals Pharmaceuticals — Research expenses decreased by 3.6% to $202.50M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 2.3%, from $207.30M to $202.50M. Over 3 years (FY 2022 to FY 2025), Pharmaceuticals — Research expenses shows an upward trend with a 9.7% CAGR.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2022
Last reportedQ4 2025
How to read this metric
An increase suggests a commitment to long-term innovation, though it may temporarily reduce current profitability.
Detailed definition
Costs incurred for early-stage discovery and basic research activities aimed at identifying new drug candidates. These i...
Peer comparison
Commonly reported as 'Research and Development' (R&D) expenses in the industry.
Metric ID:
vrtx_segment_pharmaceuticals_research_expensesHistorical Data
16 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $156.68M | $156.68M | $156.68M | $156.68M | $176.40M | $176.40M | $176.40M | $176.40M | $196.10M | $207.30M | $193.80M | $207.30M | $206.10M | $209.30M | $210.00M | $202.50M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +12.6% | +0.0% | +0.0% | +0.0% | +11.2% | +5.7% | -6.5% | +7.0% | -0.6% | +1.6% | +0.3% | -3.6% |
| YoY Change | — | — | — | — | +12.6% | +12.6% | +12.6% | +12.6% | +11.2% | +17.5% | +9.9% | +17.5% | +5.1% | +1.0% | +8.4% | -2.3% |
Range$156.68M – $210.00M
CAGR+7.1%
Avg YoY Growth+9.9%
Median YoY Growth+11.9%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's pharmaceuticals — research expenses?
- Vertex Pharmaceuticals (VRTX) reported pharmaceuticals — research expenses of $202.50M in Q4 2025.
- How has Vertex Pharmaceuticals's pharmaceuticals — research expenses changed year-over-year?
- Vertex Pharmaceuticals's pharmaceuticals — research expenses decreased by 2.3% year-over-year, from $207.30M to $202.50M.
- What is the long-term trend for Vertex Pharmaceuticals's pharmaceuticals — research expenses?
- Over 3 years (2022 to 2025), Vertex Pharmaceuticals's pharmaceuticals — research expenses has grown at a 9.7% compound annual growth rate (CAGR), from $626.70M to $827.90M.
- What does pharmaceuticals — research expenses mean?
- Spending on early-stage scientific research to discover new potential medicines.